Kaity Molenda

Kaity Molenda practices at Western New York Dermatology in Williamsville, New York.

Kaity Molenda's NPI, 1982183661, was assigned on August 13, 2018.

Kaity Molenda's primary practice is Western New York Dermatology, at 297 Spindrift Dr Suite 100 Suite 100, Williamsville, NY 14221-7894. The practice phone is (716) 831-2600.

Kaity Molenda's primary practice is Western New York Dermatology in Williamsville, New York. The medical group on file is Western New York Dermatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Kaity Molenda practices. Vendor and product names are available with a free account.

Physician assistant is Kaity Molenda's primary specialty in the NPI Registry, under taxonomy code 363A00000X.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, corns and calluses, itchy rashes, joint cyst and minor injury to a limb among the conditions Kaity Molenda treats.

CMS data shows 723 Medicare services from Kaity Molenda across 8 procedure codes in 2024, for 204 Medicare patients. Medicare paid $24,805 for them. Every service was in an office.

CMS counts 204 Medicare patients who saw Kaity Molenda in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Kaity Molenda's median patient age at 58, with 66% women.

In 2024, Kaity Molenda wrote 1,659 Medicare Part D claims for 474 patients. 88% of them were for generic drugs. CMS names the drug for 1,510 of them, across 30 drugs with 11 or more claims each, at $632,682 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Kaity Molenda for performance year 2024, reported as part of a group. Kaity Molenda accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 115 general payments to Kaity Molenda from 16 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $268.